{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:33:29Z","timestamp":1787567609520,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220530144814033"],"award-info":[{"award-number":["JCYJ20220530144814033"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515010690"],"award-info":[{"award-number":["2023A1515010690"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06685-7","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:28:21Z","timestamp":1787563701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Individual and composite socioeconomic inequalities in diagnosis, treatment, and survival of kidney cancer: a population-based analysis of the SEER database"],"prefix":"10.1007","volume":"44","author":[{"given":"Shiqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"6","key":"6685_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfae036","volume":"39","author":"L Cirillo","year":"2024","unstructured":"Cirillo L, Innocenti S, Becherucci F (2024) Global epidemiology of kidney cancer. Nephrol Dial Transpl 39(6):920\u2013928. https:\/\/doi.org\/10.1093\/ndt\/gfae036","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"6685_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"6685_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY (2024) Renal Cell Carcinoma: A Review. JAMA 332(12):1001\u20131010. https:\/\/doi.org\/10.1001\/jama.2024.12848","journal-title":"JAMA"},{"issue":"1","key":"6685_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1186\/s12889-022-13366-8","volume":"22","author":"MH Lindberg","year":"2022","unstructured":"Lindberg MH, Chen G, Olsen JA et al (2022) Combining education and income into a socioeconomic position score for use in studies of health inequalities. BMC Public Health 22(1):969. https:\/\/doi.org\/10.1186\/s12889-022-13366-8","journal-title":"BMC Public Health"},{"issue":"7","key":"6685_CR5","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1097\/JS9.0000000000002482","volume":"111","author":"X Li","year":"2025","unstructured":"Li X, Wang Y, Tao L et al (2025) Association between socioeconomic status and multimorbidity indices across 15 countries: a multi-regional cohort study. Int J Surg 111(7):4799\u20134803. https:\/\/doi.org\/10.1097\/JS9.0000000000002482","journal-title":"Int J Surg"},{"issue":"1","key":"6685_CR6","doi-asserted-by":"publisher","first-page":"9993","DOI":"10.1038\/s41467-024-54444-2","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, He Y, Liu J et al (2024) An umbrella review of socioeconomic status and cancer. Nat Commun 15(1):9993. https:\/\/doi.org\/10.1038\/s41467-024-54444-2","journal-title":"Nat Commun"},{"key":"6685_CR7","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.lanepe.2022.100551","volume":"25","author":"S Vaccarella","year":"2023","unstructured":"Vaccarella S, Georges D, Bray F et al (2023) Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study. Lancet Reg Health Eur 25:100551. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100551","journal-title":"Lancet Reg Health Eur"},{"issue":"8","key":"6685_CR8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.medj.2024.04.002","volume":"5","author":"C Wang","year":"2024","unstructured":"Wang C, Zheng Y, Luo Z et al (2024) Socioeconomic characteristics, cancer mortality, and universal health coverage: A global analysis. Med 5(8):926\u2013942e3. https:\/\/doi.org\/10.1016\/j.medj.2024.04.002","journal-title":"Med"},{"issue":"3","key":"6685_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.urolonc.2023.12.011","volume":"42","author":"C Connors","year":"2024","unstructured":"Connors C, Levy M, Chin CP et al (2024) Differences in cancer presentation, treatment, and mortality between rural and urban patients diagnosed with kidney cancer in the United States. Urol Oncol 42(3):72. https:\/\/doi.org\/10.1016\/j.urolonc.2023.12.011","journal-title":"Urol Oncol"},{"key":"6685_CR10","doi-asserted-by":"publisher","first-page":"107327482513344","DOI":"10.1177\/10732748251334455","volume":"32","author":"YL Eaglehouse","year":"2025","unstructured":"Eaglehouse YL, Darmon S, Shriver CD et al (2025) Racial-Ethnic Comparisons in Surgical Treatment and Outcomes of Non-Metastatic Renal Cell Cancer in an Equal Access Health System. Cancer Control 32:10732748251334455. https:\/\/doi.org\/10.1177\/10732748251334455","journal-title":"Cancer Control"},{"issue":"3","key":"6685_CR11","doi-asserted-by":"publisher","first-page":"102327","DOI":"10.1016\/j.clgc.2025.102327","volume":"23","author":"JT Kanumuambidi","year":"2025","unstructured":"Kanumuambidi JT, Tumin D, Blute M Jr (2025) Racial Differences in Survival for Locally Advanced Renal Cell Carcinoma. Clin Genitourin Cancer 23(3):102327. https:\/\/doi.org\/10.1016\/j.clgc.2025.102327","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"6685_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.urolonc.2021.11.004","volume":"40","author":"BK Wallace","year":"2022","unstructured":"Wallace BK, Miles CH, Anderson CB (2022) Effects of race and socioeconomic status on treatment for localized renal masses in New York City. Urol Oncol 40(2):65. https:\/\/doi.org\/10.1016\/j.urolonc.2021.11.004","journal-title":"Urol Oncol"},{"issue":"9","key":"6685_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.urolonc.2017.05.001","volume":"35","author":"J Katsnelson","year":"2017","unstructured":"Katsnelson J, Barnes RJ, Patel HA et al (2017) Effect of median household income on surgical approach and survival in renal cell carcinoma. Urol Oncol 35(9):541. https:\/\/doi.org\/10.1016\/j.urolonc.2017.05.001","journal-title":"Urol Oncol"},{"issue":"2","key":"6685_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.clgc.2024.01.016","volume":"22","author":"C Siech","year":"2024","unstructured":"Siech C, Morra S, Scheipner L et al (2024) Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages. Clin Genitourin Cancer 22(2):593\u2013598. https:\/\/doi.org\/10.1016\/j.clgc.2024.01.016","journal-title":"Clin Genitourin Cancer"},{"issue":"21","key":"6685_CR15","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.2217\/fon-2018-0827","volume":"15","author":"SL Zhang","year":"2019","unstructured":"Zhang SL, Zhang ZY, Liu ZJ et al (2019) A real-world study of socioeconomic factors with survival in adults aged 18\u201364 years with renal cell carcinoma. Future Oncol 15(21):2503\u20132515. https:\/\/doi.org\/10.2217\/fon-2018-0827","journal-title":"Future Oncol"},{"issue":"1","key":"6685_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2017.74.2049","volume":"36","author":"L Ellis","year":"2018","unstructured":"Ellis L, Canchola AJ, Spiegel D et al (2018) Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics. J Clin Oncol 36(1):25\u201333. https:\/\/doi.org\/10.1200\/JCO.2017.74.2049","journal-title":"J Clin Oncol"},{"key":"6685_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.urology.2021.05.085","volume":"163","author":"MC DeRouen","year":"2022","unstructured":"DeRouen MC, Yang J, Jain J et al (2022) Disparities in Prostate Cancer Survival According to Neighborhood Archetypes, A Population-Based Study. Urology 163:138\u2013147. https:\/\/doi.org\/10.1016\/j.urology.2021.05.085","journal-title":"Urology"},{"key":"6685_CR18","unstructured":"Surveillance Epidemiology, and End Results (SEER) Program. Available from: https:\/\/seer.cancer.gov\/ (Accessed 2 March 2026)"},{"key":"6685_CR19","unstructured":"Surveillance E, Results E (2024) (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2024 Sub (2000\u20132022), National Cancer Institute, DCCPS, Surveillance Research Program, released April 2025, based on the November submission"},{"issue":"11","key":"6685_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.urolonc.2023.08.016","volume":"41","author":"R Alam","year":"2023","unstructured":"Alam R, Rezaee ME, Pallauf M et al (2023) Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma. Urol Oncol 41(11):460. https:\/\/doi.org\/10.1016\/j.urolonc.2023.08.016","journal-title":"Urol Oncol"},{"issue":"4","key":"6685_CR21","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.21037\/tau-20-1045","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, Zhu MX, Zhang B (2020) The impact of insurance status on the survival outcomes of patients with renal cell carcinoma. Transl Androl Urol 9(4):1678\u20131690. https:\/\/doi.org\/10.21037\/tau-20-1045","journal-title":"Transl Androl Urol"},{"issue":"11","key":"6685_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.urolonc.2024.06.012","volume":"42","author":"L Holland","year":"2024","unstructured":"Holland L, Bhanvadia R, Ibeziako N et al (2024) Socioeconomic and Demographic Disparities in Immunotherapy Utilization for Advanced Kidney and Bladder Cancer. Urol Oncol 42(11):374. https:\/\/doi.org\/10.1016\/j.urolonc.2024.06.012","journal-title":"Urol Oncol"},{"issue":"8","key":"6685_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.urolonc.2018.05.006","volume":"36","author":"A Kaldany","year":"2018","unstructured":"Kaldany A, Blum KA, Paulucci DJ et al (2018) An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States. Urol Oncol 36(8):363. https:\/\/doi.org\/10.1016\/j.urolonc.2018.05.006","journal-title":"Urol Oncol"},{"issue":"23","key":"6685_CR24","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.3390\/cancers16233975","volume":"16","author":"L Holmes Jr","year":"2024","unstructured":"Holmes L Jr, Masire P, Eaton A et al (2024) Pediatric Renal Cell Carcinoma (pRCC) Subpopulation Environmental Differentials in Survival Disadvantage of Black\/African American Children in the United States: Large-Cohort Evidence. Cancers (Basel) 16(23):3975. https:\/\/doi.org\/10.3390\/cancers16233975","journal-title":"Cancers (Basel)"},{"issue":"20","key":"6685_CR25","doi-asserted-by":"publisher","first-page":"e70120","DOI":"10.1002\/cncr.70120","volume":"131","author":"X Lu","year":"2025","unstructured":"Lu X, Bernhard JC, Margue G et al (2025) Racial differences in kidney cancer histology and outcome: A nationwide study from the UroCCR Cohort. Cancer 131(20):e70120. https:\/\/doi.org\/10.1002\/cncr.70120","journal-title":"Cancer"},{"issue":"3","key":"6685_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.euf.2017.12.006","volume":"5","author":"M Alameddine","year":"2019","unstructured":"Alameddine M, Koru-Sengul T, Moore KJ et al (2019) Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses. Eur Urol Focus 5(3):482\u2013487. https:\/\/doi.org\/10.1016\/j.euf.2017.12.006","journal-title":"Eur Urol Focus"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06685-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:28:23Z","timestamp":1787563703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6685"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06685-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data utilized in this research is publicly accessible and contains no identifiable patient information. Consequently, this study did not require an ethics committee review or patient consent.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors listed have granted consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"601"}}